| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Annexon, Inc. | EVP & Chief Medical Officer | Common Stock | 12,500 | $56,528 | $4.52 | 11 Feb 2022 | Direct |
| Annexon, Inc. | EVP & Chief Medical Officer | Stock Option (Right to Buy) | 100,000 | 11 Feb 2022 | Direct | ||
| NEUROCRINE BIOSCIENCES INC | Chief Medical Officer | Stock Option | 70,101 | 02 Jun 2025 | Direct | ||
| NEUROCRINE BIOSCIENCES INC | Chief Medical Officer | Restricted Stock Unit | 12,846 | 02 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NBIX | NEUROCRINE BIOSCIENCES INC | 02 Jun 2025 | 2 | $0 | 4 | Chief Medical Officer | 04 Jun 2025, 17:37 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 02 Jun 2025 | 0 | $0 | 3 | Chief Medical Officer | 04 Jun 2025, 17:34 |
| ANNX | Annexon, Inc. | 11 Feb 2022 | 2 | $0 | 4 | EVP & Chief Medical Officer | 15 Feb 2022, 15:37 |